D.E. Shaw & Co’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Sell |
|
|||||
|
2025
Q1 | $3.87M | Buy |
|
|||||
|
2024
Q4 | $3.25M | Buy |
|
|||||
|
2024
Q3 | $1.65M | Buy |
|
|||||
|
2024
Q2 | $490K | Sell |
|
|||||
|
2024
Q1 | $1.39M | Sell |
|
|||||
|
2023
Q4 | $2.78M | Sell |
|
|||||
|
2023
Q3 | $5.66M | Sell |
|
|||||
|
2023
Q2 | $12.6M | Buy |
|
|||||
|
2023
Q1 | $2.85M | Sell |
|
|||||
|
2022
Q4 | $2.46M | Sell |
|
|||||
|
2022
Q3 | $1.76M | Buy |
|
|||||
|
2022
Q2 | $33K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $324K | Buy |
|
|||||
|
2021
Q2 | $92K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $103K | Sell |
|
|||||
|
2020
Q2 | $779K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $107K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $50K | Sell |
|
|||||
|
2019
Q1 | $49K | Sell |
|
|||||
|
2018
Q4 | $118K | Sell |
|
|||||
|
2018
Q3 | $297K | Sell |
|
|||||
|
2018
Q2 | $1.06M | Buy |
|
|||||
|
2018
Q1 | $696K | Sell |
|
|||||
|
2017
Q4 | $2.11M | Buy |
|
|||||
|
2017
Q3 | $2.67M | Sell |
|
|||||
|
2017
Q2 | $2.97M | Buy |
|
|||||
|
2017
Q1 | $2.42M | Buy |
|
|||||
|
2016
Q4 | $2.45M | Buy |
|
|||||
|
2016
Q3 | $2.74M | Buy |
|
|||||
|
2016
Q2 | $1.64M | Buy |
|
|||||
|
2016
Q1 | $1.22M | Buy |
|
|||||
|
2015
Q4 | $1.28M | Sell |
|
|||||
|
2015
Q3 | $2.67M | Buy |
|
|||||
|
2015
Q2 | $2.21M | Buy |
|
|||||
|
2015
Q1 | $1.3M | Sell |
|
|||||
|
2014
Q4 | $11.3M | Sell |
|
|||||
|
2014
Q3 | $9.97M | Buy |
|
|||||
|
2014
Q2 | $8.65M | Buy |
|